Radioimmunoassay Market Size, Share, Growth, Trends and Forecast to 2035
The Radioimmunoassay Market is witnessing steady expansion as healthcare organizations, diagnostic laboratories, and research institutions continue to require highly sensitive analytical technologies. According to Market Research Future, the market was valued at approximately USD 0.84 billion in 2025 and is projected to reach USD 1.49 billion by 2035, registering a CAGR of 5.9% during 2026–2035.
Rising rates of cancer and chronic diseases are increasing demand for accurate biomarker and hormone testing. Radioimmunoassay remains useful in applications involving endocrinology, oncology, infectious diseases, and immunology because of its ability to detect low concentrations of specific substances.
Technological developments are also influencing market growth. Automated analyzers, improved sample handling, digital quality-control systems, and laboratory connectivity are helping reduce manual intervention and improve testing efficiency. At the same time, expanding diagnostic infrastructure in emerging economies is creating new opportunities for assay manufacturers.
North America currently represents a leading regional market, while Asia-Pacific is projected to experience faster growth because of healthcare infrastructure development and increasing diagnostic requirements. However, competition from non-radioactive immunoassay technologies and radioactive waste-management requirements remain important challenges.
Overall, increasing diagnostic needs, laboratory modernization, research applications, and technological innovation are expected to support continued development of the global Radioimmunoassay Market through 2035.